Cetera Investment Advisers’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.4M | Buy |
348,145
+13,412
| +4% | +$1.44M | 0.06% | 316 |
|
|
2025
Q1 | $33.8M | Buy |
334,733
+15,572
| +5% | +$1.57M | 0.07% | 304 |
|
|
2024
Q4 | $28.5M | Buy |
319,161
+14,789
| +5% | +$1.32M | 0.06% | 331 |
|
|
2024
Q3 | $25.5M | Buy |
304,372
+8,388
| +3% | +$703K | 0.06% | 351 |
|
|
2024
Q2 | $22.8M | Buy |
295,984
+8,399
| +3% | +$647K | 0.05% | 364 |
|
|
2024
Q1 | $19.7M | Buy |
287,585
+218,573
| +317% | +$15M | 0.05% | 396 |
|
|
2023
Q4 | $3.99M | Sell |
69,012
-607
| -0.9% | -$35.1K | 0.03% | 517 |
|
|
2023
Q3 | $3.68M | Buy |
69,619
+2,303
| +3% | +$122K | 0.03% | 518 |
|
|
2023
Q2 | $3.64M | Buy |
67,316
+6,962
| +12% | +$377K | 0.03% | 524 |
|
|
2023
Q1 | $3.02M | Buy |
60,354
+16,628
| +38% | +$832K | 0.03% | 570 |
|
|
2022
Q4 | $2.02M | Buy |
43,726
+14,568
| +50% | +$674K | 0.02% | 709 |
|
|
2022
Q3 | $1.13M | Sell |
29,158
-1,019
| -3% | -$39.5K | 0.02% | 666 |
|
|
2022
Q2 | $1.13M | Buy |
30,177
+1,384
| +5% | +$51.6K | 0.02% | 748 |
|
|
2022
Q1 | $1.28M | Buy |
28,793
+5,581
| +24% | +$247K | 0.02% | 733 |
|
|
2021
Q4 | $986K | Buy |
23,212
+2,305
| +11% | +$97.9K | 0.01% | 808 |
|
|
2021
Q3 | $907K | Buy |
20,907
+1,403
| +7% | +$60.9K | 0.01% | 805 |
|
|
2021
Q2 | $834K | Buy |
19,504
+5,986
| +44% | +$256K | 0.01% | 847 |
|
|
2021
Q1 | $522K | Sell |
13,518
-5,111
| -27% | -$197K | 0.01% | 955 |
|
|
2020
Q4 | $670K | Buy |
+18,629
| New | +$670K | 0.01% | 836 |
|